Physician profile
Michael T Dee
NPI 1801962493
$4,829.07
in general payments reported to CMS, 2019-2025
9 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,906 · 2022: $2,407 · 2023: $172 · 2024: $135 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $87.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $87.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $4,088.55 | 2021-2023 | Zynrelef |
| Medtronic, INC. | $265.52 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Stryker Corporation | $160.24 | 2021-2023 | Insignia, Mako |
| Ferring Pharmaceuticals INC. | $155.37 | 2021-2023 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $58.60 | 2025 | |
| Pacira Therapeutics, INC. | $53.24 | 2021 | |
| Pfizer INC. | $20.65 | 2025 | |
| Orthofix Medical, INC. | $13.86 | 2021 | |
| Smith+Nephew, INC. | $13.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.